AS

Angelica Sanabria

IB Inhibrx Biosciences: 5 patents #4 of 26Top 20%
IN Inhibrx: 3 patents #14 of 23Top 65%
RP Regeneron Pharmaceuticals: 1 patents #552 of 810Top 70%
📍 Village of La Jolla, CA: #449 of 2,316 inventorsTop 20%
🗺 California: #73,997 of 386,348 inventorsTop 20%
Overall (All Time): #601,664 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12421315 CLL-1 targeted immunotherapies Jordan Jarjour, Mark Pogson, Wai-Hang Leung, Lucas Rascon, John C. Timmer +1 more 2025-09-23
12365728 DLL3 single domain antibodies and therapeutic compositions thereof Brendan P. Eckelman, Michael D. KAPLAN, Katelyn M. Willis, Rajay Pandit, Sydney A. Barnes +2 more 2025-07-22
12297271 PD-1 single domain antibodies and therapeutic compositions thereof Rajay Pandit, John C. Timmer, Florian Sulzmaier, Brendan P. Eckelman 2025-05-13
12084502 CD33-binding polypeptides and uses thereof Kyle S. Jones, William Crago, Andrew Hollands, Jacob Gano, Milton Ma +2 more 2024-09-10
12043667 CLEC12a binding polypeptides and uses thereof Lucas Rascon, John C. Timmer, Brendan P. Eckelman 2024-07-23
11945869 PD-1 single domain antibodies and therapeutic compositions thereof Rajay Pandit, John C. Timmer, Florian Sulzmaier, Brendan P. Eckelman 2024-04-02
11560428 CD33-binding polypeptides and uses thereof Kyle S. Jones, William Crago, Andrew Hollands, Jacob Gano, Milton Ma +2 more 2023-01-24
11208485 PD-1 single domain antibodies and therapeutic compositions thereof Rajay Pandit, John C. Timmer, Florian Sulzmaier, Brendan P. Eckelman 2021-12-28